Abstract
Background: Hepatocellular carcinoma (HCC) is one of the leading causes of death worldwide. The commonly used criteria for listing patients with HCC for treatment with living donor liver transplantation (LDTL) are: Milan criteria and University of California, San Francisco (UCSF) criteria. Both Milan and UCSF criteria focus on the tumour burden. We have analyzed our experience with LDTL in patients with HCC and Hepatitis C virus (HCV) associated liver disease in order to determine if alpha-fetoprotein (AFP) level is a better predictor of outcome than the tumour burden.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Clinical oncology (Royal College of Radiologists (Great Britain))
Paper Title
Journal
Date
